Surgical and procedural prophylaxis

Quality statement 8

A patient having surgery or a procedure is prescribed antimicrobial prophylaxis in accordance with the current Therapeutic Guidelines or evidence-based, locally endorsed guidelines. This includes recommendations about the need for prophylaxis, choice of antimicrobial, dose, route and timing of administration, and duration.

Review of therapy

Quality statement 7

A patient prescribed an antimicrobial has regular clinical review of their therapy, with the frequency of review dependent on patient acuity and risk factors. The need for ongoing antimicrobial use, appropriate microbial spectrum of activity, dose, frequency and route of administration are assessed and adjusted accordingly. Investigation results are reviewed promptly when they are reported.


Quality statement 6

When a patient is prescribed an antimicrobial, the indication, active ingredient, dose, frequency and route of administration, and the intended duration or review plan are documented in the patient’s healthcare record.

Patient information and shared decision making

Quality statement 5

A patient with an infection, or at risk of an infection, is provided with information about their condition and treatment options in a way that they can understand. If antimicrobials are prescribed, information on how to use them, when to stop, potential side effects and a review plan is discussed with the patient.

Microbiological testing

Quality statement 4

A patient with a suspected infection has appropriate samples taken for microbiology testing as clinically indicated, preferably before starting antimicrobial therapy.

Adverse reactions to antimicrobials

Quality statement 3

When an adverse reaction (including an allergy) to an antimicrobial is reported by a patient or recorded in their healthcare record, the active ingredient(s), date, nature and severity of the reaction are assessed and documented. This enables the most appropriate antimicrobial to be used when required.

Use of guidelines

Quality statement 2

When a patient is prescribed an antimicrobial, this is done in accordance with the current Therapeutic Guidelines or evidence-based, locally endorsed guidelines and the antimicrobial formulary.

Life-threatening conditions

Quality statement 1

A patient with a life-threatening condition due to a suspected infection receives an appropriate antimicrobial immediately, without waiting for the results of investigations.

Quality statements

The Antimicrobial Stewardship Clinical Care Standard includes eight quality statements describing the key components of care that patients can expect when they have, or are suspected of having, an infection.

Acute Anaphylaxis Clinical Care Standard

Anaphylaxis is the most severe form of allergic reaction, and is potentially life threatening if not treated immediately. The recognition of acute anaphylaxis and the provision of appropriate treatment and follow-up care are essential for improved outcomes.

Low Back Pain Clinical Care Standard

The Commission is developing a Low Back Pain Clinical Care Standard to provide guidance to clinicians and health service organisations when investigating and managing low back pain.

Colonoscopy Clinical Care Standard - webinars for health professionals

The Commission conducted a number of webinars for nurses, colonoscopists, GPs and quality managers from August to October 2020. The purpose of the webinars was to promote the Colonoscopy Clinical Care Standard and the implementation resources developed by the Commission.

The webinar recordings can be viewed below.


Quality Statements - scope and goal

The  Acute Coronary Syndromes Clinical Care Standard includes six quality statements describing the care that a patient with acute coronary syndrome should be offered.

Timely reperfusion

Quality Statement 3

A patient with an acute ST-segment-elevation myocardial infarction (STEMI), for whom emergency reperfusion is clinically appropriate, is offered timely percutaneous coronary intervention (PCI) or fibrinolysis in accordance with the time frames recommended in the current National Heart Foundation of Australia/Cardiac Society of Australia and New Zealand guidelines for the management of acute coronary syndromes. In general, primary PCI is recommended if the time from first medical contact to balloon inflation is anticipated to be less than 90 minutes; otherwise, the patient is offered fibrinolysis.